Bispecific Antibody Pipeline Congress will unite all the key opinion leaders including regulators, clinicians, and industry experts to deepen our understanding of bispecific therapeutics and exchange innovative ideas to foster meaningful research collaborations. Our 3-day bispecific-focused meeting emphasizes new and unpublished insights that are not widely shared in the scientific community.
Join your peers to discuss platform designs, execution strategies, and share safety data to maximize clinical performance of your candidates in an intimate setting which encourages close interactions and exchange of information.
